Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
2018-01-01 Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G
Are we ready to use TMB in breast cancer clinical practice?
2020-01-01 Ravaioli, S.; Limarzi, F.; Tumedei, M. M.; Palleschi, M.; Maltoni, R.; Bravaccini, S.
Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry
2014-01-01 Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter
2020-01-01 Bravaccini, S; Ravaioli, S; Tumedei, Mm; Rocca, A; Palleschi, M; Puccetti, M; Parrella, P; Altini, M; Maltoni, R
Benefit from anthracyclines in relation to biological profiles in early breast cancer
2014-01-01 Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D
Biofunctional characteristics of in situ and invasive breast carcinoma
2013-01-01 Bravaccini, S; Granato, Am; Medri, L; Foca, F; Falcini, F; Zoli, W; Ricci, M; Lanzanova, G; Masalu, N; Serra, L; Buggi, F; Folli, S; Silvestrini, R; Amadori, D
CAR T cells targeting options in the fight against multiple myeloma
2021-01-01 Nicolini, F; Bravaccini, S; Mazza, M; Gruszka, Am; Tazzari, M; Martin-Antonio, B; Juan, M; Ibrahim, T; Maltoni, R; Martinelli, G; Cerchione, C
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
2020-01-01 Vergara, D; Ravaioli, S; Fonzi, E; Adamo, L; Damato, M; Bravaccini, S; Pirini, F; Gaballo, A; Barbano, R; Pasculli, B; Franck, J; Fournier, I; Salzet, M; Maffia, M
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
2019-01-01 Bravaccini, S; Maltoni, R
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
2017-01-01 Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer
2020-01-01 Fabbri, F; Salvi, S; Bravaccini, S
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China
2022-01-01 Li, Q; Zhou, Q; Zhao, S; Wu, P; Shi, P; Zeng, J; Xiong, X; Chen, H; Kittaneh, M; Bravaccini, S; Zanoni, M; Zhou, C; Zhang, J
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy
2014-01-01 Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A.
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
2020-01-01 Rossi, T; Vergara, D; Fanini, F; Maffia, M; Bravaccini, S; Pirini, F
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue
2013-01-01 Ulivi, P; Puccetti, M; Capelli, L; Chiadini, E; Bravaccini, S; Calistri, D; Zoli, W; Amadori, D; Candoli, P
New Biomarkers to Predict the Evolution of In Situ Breast Cancers
2014-01-01 Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
2016-01-01 Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer
2014-01-01 Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
2022-01-01 Cortesi, M; Zanoni, M; Pirini, F; Tumedei, Mm; Ravaioli, S; Rapposelli, Ig; Frassineti, Gl; Bravaccini, S
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report
2016-01-01 Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? | 1-gen-2018 | Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G | |
| Are we ready to use TMB in breast cancer clinical practice? | 1-gen-2020 | Ravaioli, S.; Limarzi, F.; Tumedei, M. M.; Palleschi, M.; Maltoni, R.; Bravaccini, S. | |
| Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry | 1-gen-2014 | Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D | |
| Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter | 1-gen-2020 | Bravaccini, S; Ravaioli, S; Tumedei, Mm; Rocca, A; Palleschi, M; Puccetti, M; Parrella, P; Altini, M; Maltoni, R | |
| Benefit from anthracyclines in relation to biological profiles in early breast cancer | 1-gen-2014 | Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D | |
| Biofunctional characteristics of in situ and invasive breast carcinoma | 1-gen-2013 | Bravaccini, S; Granato, Am; Medri, L; Foca, F; Falcini, F; Zoli, W; Ricci, M; Lanzanova, G; Masalu, N; Serra, L; Buggi, F; Folli, S; Silvestrini, R; Amadori, D | |
| CAR T cells targeting options in the fight against multiple myeloma | 1-gen-2021 | Nicolini, F; Bravaccini, S; Mazza, M; Gruszka, Am; Tazzari, M; Martin-Antonio, B; Juan, M; Ibrahim, T; Maltoni, R; Martinelli, G; Cerchione, C | |
| Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling | 1-gen-2020 | Vergara, D; Ravaioli, S; Fonzi, E; Adamo, L; Damato, M; Bravaccini, S; Pirini, F; Gaballo, A; Barbano, R; Pasculli, B; Franck, J; Fournier, I; Salzet, M; Maffia, M | |
| CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? | 1-gen-2019 | Bravaccini, S; Maltoni, R | |
| Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer | 1-gen-2017 | Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S | |
| Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer | 1-gen-2020 | Fabbri, F; Salvi, S; Bravaccini, S | |
| KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China | 1-gen-2022 | Li, Q; Zhou, Q; Zhao, S; Wu, P; Shi, P; Zeng, J; Xiong, X; Chen, H; Kittaneh, M; Bravaccini, S; Zanoni, M; Zhou, C; Zhang, J | |
| Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy | 1-gen-2014 | Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A. | |
| Microbiota-Derived Metabolites in Tumor Progression and Metastasis | 1-gen-2020 | Rossi, T; Vergara, D; Fanini, F; Maffia, M; Bravaccini, S; Pirini, F | |
| Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue | 1-gen-2013 | Ulivi, P; Puccetti, M; Capelli, L; Chiadini, E; Bravaccini, S; Calistri, D; Zoli, W; Amadori, D; Candoli, P | |
| New Biomarkers to Predict the Evolution of In Situ Breast Cancers | 1-gen-2014 | Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R | |
| Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy | 1-gen-2016 | Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A | |
| Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer | 1-gen-2014 | Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D | |
| Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight | 1-gen-2022 | Cortesi, M; Zanoni, M; Pirini, F; Tumedei, Mm; Ravaioli, S; Rapposelli, Ig; Frassineti, Gl; Bravaccini, S | |
| Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report | 1-gen-2016 | Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15368
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267039
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10819
- ita2587
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15371